ArticleVaccines2025

Safety and Immunogenicity of sIPV in Healthy Infants Aged 2 Months Following Sequential Immunization Program Combination with bOPV: A Phase 3, Randomized, Blinded, Parallel Positive-Controlled Clinical Trial.

Yafei Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.